Literature DB >> 8359690

An engineered PGK promoter and lac operator-repressor system for the regulation of gene expression in mammalian cells.

G N Hannan1, S A Lehnert, E S MacAvoy, P A Jennings, P L Molloy.   

Abstract

Previous reports have demonstrated that the Escherichia coli lac repressor can operate effectively in mammalian cells to repress expression of genes driven by modified viral or metallothionein (MT) promoters. We have developed a more general expression system using the promoter from the PGK1 gene (encoding murine 3-phosphoglycerate kinase) which is widely expressed in almost all cell types, including early embryonic and ES (embryonic stem) cells. Firstly, we engineered the lac repressor to include a nuclear localisation signal and placed it under control of the PGK1 promoter. Efficient nuclear localisation of the repressor was demonstrated by mobility-shift assays and immunofluorescence detection. For the target vectors, we modified the wild-type (wt) PGK1 promoter to include lac operator (lacO) sites for binding of the lac repressor and compared a number of different lacO positions and arrangements based on proximity to the native start points for transcription (tsp) and translation. In the absence of repressor, we observed reduced expression of the neo reporter gene for some placements of the lacO, but wt expression for placements near the tsp. When both target and repressor were present in the cells, we observed that the expression of neo could be strongly suppressed and reversibly regulated by induction with IPTG. In particular, for a promoter which contained two spaced lacO replacing native sequence around the major tsp, we observed 90-95% repression by the lac repressor for the neo reporter gene and up to 98% repression for the cat reporter gene. Efficient derepression by IPTG was observed in both cases.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8359690     DOI: 10.1016/0378-1119(93)90424-2

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  4 in total

1.  Regulated autocrine growth of CHO cells.

Authors:  N A Sunstrom; S Hunt; C Bailey; M Baig; M Sleigh; P Gray
Journal:  Cytotechnology       Date:  2000-10       Impact factor: 2.058

2.  Correction of murine SCID-X1 by lentiviral gene therapy using a codon-optimized IL2RG gene and minimal pretransplant conditioning.

Authors:  Marshall W Huston; Niek P van Til; Trudi P Visser; Shazia Arshad; Martijn H Brugman; Claudia Cattoglio; Ali Nowrouzi; Yuedan Li; Axel Schambach; Manfred Schmidt; Christopher Baum; Christof von Kalle; Fulvio Mavilio; Fang Zhang; Mike P Blundell; Adrian J Thrasher; Monique M A Verstegen; Gerard Wagemaker
Journal:  Mol Ther       Date:  2011-07-12       Impact factor: 11.454

3.  Engineering Next-Generation BET-Independent MLV Vectors for Safer Gene Therapy.

Authors:  Sara El Ashkar; Dominique Van Looveren; Franziska Schenk; Lenard S Vranckx; Jonas Demeulemeester; Jan De Rijck; Zeger Debyser; Ute Modlich; Rik Gijsbers
Journal:  Mol Ther Nucleic Acids       Date:  2017-04-12

4.  Multi-colony stimulating activity of interleukin 5 (IL-5) on hematopoietic progenitors from transgenic mice that express IL-5 receptor alpha subunit constitutively.

Authors:  M Takagi; T Hara; M Ichihara; K Takatsu; A Miyajima
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.